Variant report
Variant | nsv961782 |
---|---|
Chromosome Location | chr2:63977227-63979716 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:63975082..63977676-chr2:64069510..64071160,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-UGP2-2 | chr2:63977594-63978119 | NONHSAT071072 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000169764 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181975626 | chr2:63977265-63977266 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs115108604 | chr2:63977296-63977297 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs534751440 | chr2:63977308-63977309 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs187364461 | chr2:63977396-63977397 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs192187031 | chr2:63977402-63977403 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs183619027 | chr2:63977473-63977474 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs188614674 | chr2:63977474-63977475 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs370125429 | chr2:63977529-63977530 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs190134456 | chr2:63977646-63977647 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs138224038 | chr2:63977652-63977653 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs577386612 | chr2:63977673-63977674 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs538360922 | chr2:63977691-63977692 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs556558988 | chr2:63977739-63977740 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs554644151 | chr2:63977790-63977791 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs574746666 | chr2:63977793-63977794 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs201225917 | chr2:63977877-63977878 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs537439220 | chr2:63977915-63977916 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs542105101 | chr2:63977926-63977927 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs560229772 | chr2:63977943-63977944 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs534158597 | chr2:63977958-63977959 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs557106653 | chr2:63978060-63978061 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs572190565 | chr2:63978076-63978077 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs545621434 | chr2:63978105-63978106 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs563961475 | chr2:63978122-63978123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149550396 | chr2:63978123-63978124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373582523 | chr2:63978175-63978176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144245227 | chr2:63978197-63978198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182371374 | chr2:63978206-63978207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548852737 | chr2:63978278-63978279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567083645 | chr2:63978427-63978428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577466091 | chr2:63978478-63978479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546219664 | chr2:63978487-63978488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186726770 | chr2:63978503-63978504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191142897 | chr2:63978518-63978519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115382874 | chr2:63978549-63978550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148472155 | chr2:63978565-63978566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs57531829 | chr2:63978577-63978578 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs556430776 | chr2:63978648-63978649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs56025046 | chr2:63978652-63978653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541921391 | chr2:63978696-63978697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556142279 | chr2:63978704-63978705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574767716 | chr2:63978706-63978707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs59189491 | chr2:63978725-63978726 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs554012821 | chr2:63978752-63978753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572219710 | chr2:63978852-63978853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs55759043 | chr2:63978871-63978872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545707232 | chr2:63978879-63978880 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114812497 | chr2:63978912-63978913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs79910719 | chr2:63978947-63978948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182768167 | chr2:63979088-63979089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:63970000-63979600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:63970200-63980400 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr2:63970400-63982200 | Weak transcription | Psoas Muscle | Psoas |
4 | chr2:63973000-63992800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr2:63973200-63990400 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr2:63974800-63982200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr2:63975200-63990200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr2:63976400-64028600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr2:63976600-63983200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr2:63978800-63979200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr2:63978800-63979800 | Enhancers | Pancreas | Pancrea |
12 | chr2:63978800-63981200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |